bioMérieux S.A. (LON: 0RUG)
London
· Delayed Price · Currency is GBP · Price in EUR
117.09
+0.16 (0.13%)
At close: Jan 31, 2025
bioMérieux Revenue
bioMérieux had revenue of 1.90B EUR in the half year ending June 30, 2024, with 14.71% growth. This brings the company's revenue in the last twelve months to 3.81B, up 2.85% year-over-year. In the year 2023, bioMérieux had annual revenue of 3.67B with 2.39% growth.
Revenue (ttm)
3.81B EUR
Revenue Growth
+2.85%
P/S Ratio
n/a
Revenue / Employee
272.24K EUR
Employees
13,982
Market Cap
11.56B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.67B | 85.60M | 2.39% |
Dec 31, 2022 | 3.59B | 212.90M | 6.31% |
Dec 31, 2021 | 3.38B | 258.00M | 8.27% |
Dec 31, 2020 | 3.12B | 443.40M | 16.58% |
Dec 31, 2019 | 2.67B | 253.50M | 10.47% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
Shell | 227.10B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
British American Tobacco p.l.c. | 26.18B |
BP p.l.c. | 144.69B |